Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2022 Jul 1;31(7):1450–1459. doi: 10.1158/1055-9965.EPI-21-1287

Table 1:

Patient Characteristics and histological subtypes

Characteristics LUAD (n=3886) LUSQ (n=517) SCLC (n=275) Other Histological Subtypes (n=440)
Median age at diagnosis (years) 70 75 70 70
Sex
 Male 1509 (38.9%) 336 (65%) 142 (51.6%) 200 (45.5%)
 Female 2377 (60.1%) 181 (35%( 133 (48.4%) 240 (55.5%)
Smoking History
 Smoker (current or former) 2611 (67.2%) 433 (83.7%) 203 (73.8%) 296 (62.2%)
 Non-smoker 1006 (25.9%) 22 (4.2%) 15 (5.4%) 71 (16.1%)
 Unknown/missing data 269 (6.9%) 62 (12%) 57 (20.7%) 73 (16.6%)
Ethnicity (self-reported)
 European/White/Non-Hispanic 2430 (62.5%) 377 (72.9%) 218 (79.2%) 293 (66.6%)
 Ashkenazi Jewish 643 (16.5%) 53 (10.2%) 24 (8.7%) 54 (12.3%)
 Asian 399 (10.3%) 27 (5.2%) 15 (5.4%) 24 (5.4%)
 African 191 (4.9%) 30 (5.8%) 8 (2.9%) 34 (7.7%)
 Others/Unknown 223 (5.7%) 30 (5.8%) 10 (3.6%) 35 (7.9%)
Disease Stage
 Non- Metastatic 484 (12.5%) 44 (8.5%) 18 (6.5%) 112 (25.5%)
 Metastatic 3341 (86%) 462 (89.3%) 251 (91.3%) 318 (72.2%)
 Missing data 61 (1.8%) 11 (2.1%) 6 (2.2%) 10 (2.3%)
Personal History of Multiple primary tumors
 Yes 1023 (26.3%) 133 (25.7%) 58 (21%) 107 (24.3%)

Abbreviation: LUAD= Lung Adenocarcinoma, LUSQ= Lung Squamous Cell Carcinoma, SCLC= Small Cell Lung Cancer